The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes
Year: 2002
Type: article
Study design: Clinical Trial
Source: Metabolism
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2055928432
